Taking Internal Combustion Engines (ICE) to the Next Level
September 19, 2024 16:40 ET
|
Engine Technology Forum
Washington, D.C., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Six industry experts share insights about the innovations occurring in advanced internal combustion engines and fuels in an Engine Technology...
ART SHARE 003 launches the initial offering of the iconic artwork ‘Abstraktes Bild (809-4)’ by Gerhard Richter.
September 18, 2024 01:31 ET
|
Art Share 003
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER STATE OR...
Sugar Substitutes Market Surges to USD 25.4 Billion by 2031, Propelled by 4.42% CAGR - Verified Market Research®
September 17, 2024 10:00 ET
|
Verified Market Research
Lewes, Delaware, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The Global Sugar Substitutes Market Size is projected to grow at a CAGR of 4.42% from 2024 to 2031, according to a new report published by...
Global Modified Starch Market Trends Analysis Report 2024: A $17.98 Billion Industry by 2031 - Convenience Foods and Emerging Economies Drive Robust Growth
September 17, 2024 04:11 ET
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "Global Modified Starch Market Size, Share, Forecast, & Trends Analysis by Product Type, Raw Material, Production Method, Function, Form, End-use...
Les résultats finaux de l’essai de Phase III CABINET corroborent les bénéfices en termes d’efficacité de Cabometyx® dans les tumeurs neuroendocrines avancées
September 16, 2024 08:45 ET
|
Ipsen Pharma
Les données ont démontré une réduction significative, tant sur le plan statistique que sur le plan clinique, du risque de progression de la maladie ou de décès avec Cabometyx® (cabozantinib) par...
Final results from CABINET Phase III trial reinforce efficacy benefits of Cabometyx® in advanced neuroendocrine tumors
September 16, 2024 08:45 ET
|
Ipsen Pharma
Data demonstrated statistically significant and clinically meaningful reduction in risk of disease progression or death with Cabometyx® (cabozantinib) versus placebo in advanced pancreatic and...
Extreme Networks (EXTR) Tumbled 18% After Guiding For Year-Over-Year Revenue Declines, Stock Has Not Recovered - Hagens Berman
September 13, 2024 15:18 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Extreme Networks, Inc. (NASDAQ: EXTR) investors who suffered substantial losses to submit your losses now. The firm also...
Big Screen Entertainment Group Launches Big Screen Capital to Fund a Range of New Projects
September 13, 2024 09:33 ET
|
Big Screen Entertainment Group
Big Screen Entertainment Launches Big Screen Capital to Fund Various Start Ups
LBMC Celebrates 40 Years of Transformative Growth, Career Development, and Community Impact
September 12, 2024 10:56 ET
|
LBMC
Nashville, Tenn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- In the summer of 1984, a small group of 12 visionaries set out to build something different in the business world—a firm where clients were...
Food Thickeners Market to Reach USD 25.70 Billion by 2033; Growing Demand for Bakery & Confectionary Products to Propel Growth
September 12, 2024 09:00 ET
|
The Brainy Insights
Newark, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 14.08 billion in 2023 global food thickeners market will reach USD 25.70 billion in 2033. Food thickeners are...